Leping Li*, Zhen Fang, Liang Shang
Gastric Cancer (GC) is one of the common malignant tumors. Although treatment of GC has improved, overall survival remains low. The main treatment for GC is gastrectomy. Finding the risk factors affecting the prognosis after gastrectomy and taking active treatment and intervention measures are of great significance to improve the prognosis of gastric cancer. Sarcopenia comes from the greek sarx (muscle) and penia (loss). It was first proposed by Professor Rosenberg in 1989.
The prominent feature of sarcopenia is decreased skeletal muscle mass and function. Many studies have shown that sarcopenia is closely related to the prognosis of GC patients. Many international organizations studying sarcopenia have reached consensus and established cut off points for the diagnosis of sarcopenia. Currently, sarcopenia has been officially recognized as a muscle disease with the diagnosis code: ICD-10-MC. This review discusses the research progress of sarcopenia and its relationship with GC, and looks forward to future research directions in this field.
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu